Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
2.220
0.00 (0.00%)
Nov 20, 2024, 4:00 PM EST - Market closed
Mersana Therapeutics Employees
Mersana Therapeutics had 123 employees as of December 31, 2023. The number of employees decreased by 105 or -46.05% compared to the previous year.
Employees
123
Change (1Y)
-105
Growth (1Y)
-46.05%
Revenue / Employee
$283,228
Profits / Employee
-$606,659
Market Cap
274.24M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Accolade | 2,400 |
Poseida Therapeutics | 330 |
Fate Therapeutics | 181 |
NeuroPace | 171 |
Atea Pharmaceuticals | 75 |
Ocugen | 65 |
Rezolute | 59 |
Eton Pharmaceuticals | 30 |
MRSN News
- 7 days ago - Mersana Therapeutics, Inc. (MRSN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results - GlobeNewsWire
- 15 days ago - Mersana Therapeutics to Host Third Quarter 2024 Conference Call on November 13, 2024 - GlobeNewsWire
- 3 months ago - Mersana Therapeutics, Inc. (MRSN) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Mersana Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Mersana Therapeutics to Host Second Quarter 2024 Conference Call on August 13, 2024 - GlobeNewsWire
- 6 months ago - Mersana Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire
- 6 months ago - Mersana Therapeutics, Inc. (MRSN) Q1 2024 Earnings Call Transcript - Seeking Alpha